Incyte Corporation - stock earnings
INCY Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 30, 2024 BeforeMarket | 0.64 / 0.88 | - | 880.9 million / 948.4 million | - |
INCY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 201.1 million USD | 1.0 billion USD |
| 2023Q3 | 171.3 million USD | 919.0 million USD |
| 2023Q2 | 203.5 million USD | 954.6 million USD |
| 2023Q1 | 21.7 million USD | 808.7 million USD |
| 2022Q4 | 28.5 million USD | 926.7 million USD |
| 2022Q3 | 112.8 million USD | 823.3 million USD |
| 2022Q2 | 161.4 million USD | 911.4 million USD |
| 2022Q1 | 38.0 million USD | 733.2 million USD |
| 2021Q4 | 563.9 million USD | 862.9 million USD |
| 2021Q3 | 181.7 million USD | 813.0 million USD |
| 2021Q2 | 149.5 million USD | 705.7 million USD |
| 2021Q1 | 53.5 million USD | 604.7 million USD |
| 2020Q4 | 149.9 million USD | 789.5 million USD |
| 2020Q3 | -15.2 million USD | 620.6 million USD |
| 2020Q2 | 290.3 million USD | 688.0 million USD |
| 2020Q1 | -720.6 million USD | 568.5 million USD |
| 2019Q4 | 111.0 million USD | 579.4 million USD |
| 2019Q3 | 128.3 million USD | 551.6 million USD |
| 2019Q2 | 105.3 million USD | 529.9 million USD |
| 2019Q1 | 102.3 million USD | 497.9 million USD |
| 2018Q4 | 69.1 million USD | 528.4 million USD |
| 2018Q3 | 29.2 million USD | 449.7 million USD |
| 2018Q2 | 52.4 million USD | 521.5 million USD |
| 2018Q1 | -41.1 million USD | 382.3 million USD |
| 2017Q4 | -149.6 million USD | 444.2 million USD |
| 2017Q3 | 36.1 million USD | 381.5 million USD |
| 2017Q2 | -12.5 million USD | 326.4 million USD |
| 2017Q1 | -187.1 million USD | 384.1 million USD |
| 2016Q4 | 8.9 million USD | 326.5 million USD |
| 2016Q3 | 36.9 million USD | 269.5 million USD |
| 2016Q2 | 34.4 million USD | 246.3 million USD |
| 2016Q1 | 24.0 million USD | 263.5 million USD |
| 2015Q4 | 55.2 million USD | 243.9 million USD |
| 2015Q3 | -39.6 million USD | 187.6 million USD |
| 2015Q2 | 9.3 million USD | 163.0 million USD |
| 2015Q1 | -18.4 million USD | 159.3 million USD |
| 2014Q4 | -36.9 million USD | 124.0 million USD |
| 2014Q3 | 59.3 million USD | 198.1 million USD |
| 2014Q2 | -36.9 million USD | 99.6 million USD |
| 2014Q1 | -34.0 million USD | 89.8 million USD |
| 2013Q4 | -42.9 million USD | 97.1 million USD |
| 2013Q3 | -22.0 million USD | 85.1 million USD |
| 2013Q2 | -2.6 million USD | 101.7 million USD |
| 2013Q1 | -15.7 million USD | 71.1 million USD |
| 2012Q4 | 18.8 million USD | 113.8 million USD |
| 2012Q3 | -21.7 million USD | 60.5 million USD |
| 2012Q2 | 4.0 million USD | 86.5 million USD |
| 2012Q1 | -45.4 million USD | 36.2 million USD |
| 2011Q4 | -55.1 million USD | 28.9 million USD |
| 2011Q3 | -53.1 million USD | 16.8 million USD |
| 2011Q2 | -51.9 million USD | 16.8 million USD |
| 2011Q1 | -26.5 million USD | 32.0 million USD |
| 2010Q4 | 32.5 million USD | 85.9 million USD |
| 2010Q3 | -31.7 million USD | 16.9 million USD |
| 2010Q2 | 3.0 million USD | 49.8 million USD |
| 2010Q1 | -35.7 million USD | 17.3 million USD |
| 2009Q4 | -88.4 million USD | 6.9 million USD |
| 2009Q3 | -43.4 million USD | 939000 USD |
| 2009Q2 | -40.0 million USD | 789000 USD |
| 2009Q1 | -40.0 million USD | 671000 USD |
| 2008Q4 | -48.4 million USD | 938000 USD |
| 2008Q3 | -44.8 million USD | 1.1 million USD |
| 2008Q2 | -45.6 million USD | 614000 USD |
| 2008Q1 | -40.2 million USD | 1.3 million USD |
| 2007Q4 | -21.8 million USD | 9.8 million USD |
| 2007Q3 | -24.5 million USD | 6.7 million USD |
| 2007Q2 | -18.4 million USD | 10.6 million USD |
| 2007Q1 | -22.1 million USD | 7.4 million USD |
| 2006Q4 | -20.5 million USD | 7.1 million USD |
| 2006Q3 | -15.8 million USD | 7.3 million USD |
| 2006Q2 | -20.5 million USD | 6.9 million USD |
| 2006Q1 | -17.3 million USD | 6.5 million USD |
| 2005Q4 | -27.6 million USD | 1.0 million USD |
| 2005Q3 | -30.2 million USD | 1.2 million USD |
| 2005Q2 | -25.1 million USD | 2.7 million USD |
| 2005Q1 | -20.1 million USD | 2.9 million USD |
| 2004Q4 | -37.5 million USD | -1.1 million USD |
| 2004Q3 | -26.0 million USD | 3.4 million USD |
| 2004Q2 | -63.6 million USD | 5.2 million USD |
| 2004Q1 | -37.7 million USD | 6.6 million USD |
| 2003Q4 | -40.8 million USD | 10.3 million USD |
| 2003Q3 | -43.0 million USD | 13.2 million USD |
| 2003Q2 | -26.9 million USD | 11.0 million USD |
| 2003Q1 | -55.8 million USD | 12.5 million USD |
| 2002Q4 | -67.5 million USD | 21.1 million USD |
| 2002Q3 | -38.4 million USD | 22.4 million USD |
| 2002Q2 | -17.5 million USD | 29.1 million USD |
| 2002Q1 | -145.2 million USD | 54.8 million USD |
| 2001Q4 | -145.2 million USD | 54.8 million USD |
| 2001Q3 | -17.8 million USD | 57.3 million USD |
| 2001Q2 | -9.9 million USD | 56.1 million USD |
| 2001Q1 | -7.4 million USD | 55.4 million USD |
| 2000Q4 | -7.4 million USD | 55.4 million USD |
| 2000Q3 | -7.6 million USD | 52.0 million USD |
| 2000Q2 | -6.6 million USD | 46.0 million USD |
| 2000Q1 | -8.2 million USD | 40.8 million USD |
| 1999Q4 | -6.4 million USD | 46.1 million USD |
| 1999Q3 | -11.1 million USD | 35.4 million USD |
| 1999Q2 | -7.4 million USD | 37.9 million USD |
| 1999Q1 | -1.9 million USD | 37.6 million USD |
| 1998Q4 | 1.5 million USD | 36.6 million USD |
| 1998Q3 | -6.8 million USD | 34.7 million USD |
| 1998Q2 | 5.2 million USD | 33.1 million USD |
| 1998Q1 | 3.6 million USD | 30.4 million USD |
| 1997Q4 | 4.4 million USD | 26.7 million USD |
| 1997Q3 | 3.0 million USD | 22.7 million USD |
| 1997Q2 | 1.9 million USD | 21.2 million USD |
| 1997Q1 | 1.0 million USD | 17.9 million USD |
| 1996Q4 | 200000 USD | 14.2 million USD |
| 1996Q3 | -3.4 million USD | 12.9 million USD |
| 1996Q2 | -1.6 million USD | 7.6 million USD |
| 1996Q1 | -2.0 million USD | 5.6 million USD |
| 1995Q4 | -2.2 million USD | 4.9 million USD |
| 1995Q3 | -3.0 million USD | 2.9 million USD |
| 1995Q2 | -2.9 million USD | 2.0 million USD |
| 1995Q1 | -2.0 million USD | 1.5 million USD |
| 1994Q4 | -3.8 million USD | 100000 USD |
| 1994Q3 | -3.1 million USD | 100000 USD |
| 1994Q2 | -2.5 million USD | 100000 USD |
| 1994Q1 | -2.1 million USD | 100000 USD |
| 1993Q4 | -1.4 million USD | ? USD |
| 1993Q3 | -1.4 million USD | 100000 USD |
INCY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 597.6 million USD | 3.7 billion USD |
| 2022 | 340.7 million USD | 3.4 billion USD |
| 2021 | 948.6 million USD | 3.0 billion USD |
| 2020 | -295.7 million USD | 2.7 billion USD |
| 2019 | 446.9 million USD | 2.2 billion USD |
| 2018 | 109.5 million USD | 1.9 billion USD |
| 2017 | -313.1 million USD | 1.5 billion USD |
| 2016 | 104.2 million USD | 1.1 billion USD |
| 2015 | 6.5 million USD | 753.8 million USD |
| 2014 | -48.5 million USD | 511.5 million USD |
| 2013 | -83.1 million USD | 354.9 million USD |
| 2012 | -44.3 million USD | 297.1 million USD |
| 2011 | -186.5 million USD | 94.5 million USD |
| 2010 | -31.8 million USD | 169.9 million USD |
| 2009 | -211.9 million USD | 9.3 million USD |
| 2008 | -178.9 million USD | 3.9 million USD |
| 2007 | -86.9 million USD | 34.4 million USD |
| 2006 | -74.2 million USD | 27.6 million USD |
| 2005 | -103.0 million USD | 7.8 million USD |
| 2004 | -164.8 million USD | 14.1 million USD |
| 2003 | -166.5 million USD | 47.1 million USD |
| 2002 | -136.9 million USD | 101.6 million USD |
| 2001 | -183.2 million USD | 219.3 million USD |
| 2000 | -29.7 million USD | 194.2 million USD |
| 1999 | -26.8 million USD | 157.0 million USD |
| 1998 | 3.5 million USD | 134.8 million USD |
| 1997 | 10.4 million USD | 88.4 million USD |
| 1996 | -6.8 million USD | 41.8 million USD |
| 1995 | -10.1 million USD | 12.2 million USD |
| 1994 | -11.5 million USD | 200000 USD |
| 1993 | -4.9 million USD | 300000 USD |
INCY
Price: $53.09
52 week price:
Earnings Per Share: 2.65 USD
P/E Ratio: 30.67
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Ebitda: -135.0 millionMarket Capitalization: 12.4 billion